Catalyst
Slingshot members are tracking this event:
International Phase 3 Study Results of RLX030 (seralaxin) for Acute Heart Failure Due 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
ENDP |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 02, 2017
Occurred Source:
https://clinicaltrials.gov/archive/NCT01870778/2017_03_02/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Data, Rlx030, Seralaxin, Acute Heart Failure